However, recent studies have been consistent in pointing out the hyperactivation of the interleukin-17 axis and TGF-β signaling pathway as the central elements in the pathogenesis of NAFLD, as well as other chronic liver diseases independently of underlying cause (15, 24, 29, 31, 48). Here, TGFB1 is linked to metabolic dysfunction-associated steatotic liver disease.